137 filings
POS AM
OTLC
Oncotelic Therapeutics, Inc.
18 Apr 24
Prospectus update (post-effective amendment)
5:25pm
POS AM
OTLC
Oncotelic Therapeutics, Inc.
12 Apr 24
Prospectus update (post-effective amendment)
5:15pm
D
OTLC
Oncotelic Therapeutics, Inc.
13 Jul 23
$5.00 mm in debt / options / securities to be acquired, 15 investors
12:00am
424B3
OTLC
Oncotelic Therapeutics, Inc.
2 May 23
Prospectus supplement
5:15pm
POS AM
OTLC
Oncotelic Therapeutics, Inc.
19 Apr 23
Prospectus update (post-effective amendment)
9:00pm
POS AM
qjdzcun05s79bf18t
14 Apr 23
Prospectus update (post-effective amendment)
8:27pm
424B3
nfkex vadzdtz59pi7
11 May 22
Prospectus supplement
5:10pm
POS AM
3plm84mhq1kiwq8
26 Apr 22
Prospectus update (post-effective amendment)
5:01pm
424B3
mdr28
27 Sep 21
Prospectus supplement
12:00am
424B3
gsgof be3h7zxnpo34
3 Jun 21
Prospectus supplement
1:00pm
S-8
9vvnsn39g h1
19 Apr 21
Registration of securities for employees
12:00am
D
jgn5ik7g1 w1rvl
4 Aug 20
$5M in equity / debt, sold $2M, 24 investors
10:26am
D
pkhpomijq iufov
7 May 19
$1.2M in equity / debt, sold $600K, 4 investors
5:25pm
D
oqdzuz
7 May 19
$27M in equity, sold $27M, 26 investors
5:25pm
S-8
jupszd9dnjaw
14 Aug 18
Registration of securities for employees
4:50pm
424B5
z161ynhp9hl
27 Jun 18
Prospectus supplement for primary offering
8:02am